Immunovant (IMVT) Enterprise Value Growth (1y) (2020 - 2026)
Immunovant (IMVT) Enterprise Value Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immunovant | 7.17 Bn | 7.17 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.35% |
| Dec 31, 2025 | -165.42% |
| Sep 30, 2025 | -10.35% |
| Jun 30, 2025 | -6.95% |
| Mar 31, 2025 | -12.37% |
| Dec 31, 2024 | 45.77% |
| Sep 30, 2024 | -75.21% |
| Jun 30, 2024 | -69.72% |
| Mar 31, 2024 | -68.74% |
| Dec 31, 2023 | -59.71% |
| Sep 30, 2023 | 33.48% |
| Jun 30, 2023 | 22.76% |
| Mar 31, 2023 | 23.75% |
| Dec 31, 2022 | 17.91% |
| Sep 30, 2022 | 27.41% |
| Jun 30, 2022 | -12.72% |
| Dec 31, 2021 | -24.88% |
| Sep 30, 2021 | -25.80% |
| Jun 30, 2021 | -35.22% |
| Sep 30, 2020 | -27,494.75% |